Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine serratus anterior plane block before thoracoscopic surgery
ChiCTR2400090504Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liposomal bupivacaine, bupivacaine and sufentanil in postoperative pain and anesthesia reaction (3 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Anesthesia-related adverse events within 48 hours postoperatively. Started Oct 2024; status: recruiting.
02
Drugs
liposomal bupivacainebupivacainesufentanil
03
Conditions
postoperative painanesthesia reaction
Beyond the preview
Go deeper on ChiCTR2400090504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090504.